Up next

Autoplay

Priority Review in Merkel Cell Carcinoma, Breakthrough Designation in RET-Altered Cancers, and More

3 Views • 07/17/23
Share
Embed
administrator
administrator
Subscribers
0

Gina Columbus reports on a priority review designation in Merkel cell carcinoma, a breakthrough therapy designation in select RET-altered cancers, an application submitted in pediatric ALL, and European approvals in multiple myeloma, melanoma, and ALL.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay